Topiramate and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Topiramate (topiramate), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Topiramate. It is created by eHealthMe based on reports of 48,099 people who have side effects when taking Topiramate from the FDA, and is updated regularly.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,008 drugs and 1,973 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 18, 2026

48,099 people reported to have side effects when taking Topiramate.
Among them, 54 people (0.11%) have Dermatitis - atopic.

Could Topiramate cause Dermatitis - atopic?

Among these 54 people:

How long have people been on Topiramate when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Topiramate? *

female: 72.55 %
male: 27.45 %

What is the age of people who have Dermatitis - atopic when taking Topiramate? *

What are other drugs people take besides Topiramate? *

What are other side effects people have besides Dermatitis - atopic? *

Itching: 15 people, 27.78%
Depression: 10 people, 18.52%
Rashes (redness): 9 people, 16.67%
Pain: 8 people, 14.81%
Belching (release of gas from the digestive tract): 7 people, 12.96%
Back Pain: 7 people, 12.96%
Fever: 7 people, 12.96%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 12.96%
Eye Irritation: 6 people, 11.11%
Rickets (softening of bones): 6 people, 11.11%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 11.11%
Immunoglobulins Decreased: 6 people, 11.11%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 11.11%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 4 people, 7.41%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 7.41%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.56%
Bipolar Disorder (mood disorder): 3 people, 5.56%
Polymyalgia Rheumatica (pain in many muscles): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Topiramate and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Topiramate:

Topiramate (49,809 reports)

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,008 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,973 conditions)

Related publications that referenced our studies

Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on topiramate (the active ingredients of Topiramate) and Topiramate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.